#LetsTalkValue on precision medicine & smart clinical trials with Nicolas Leupin

We all know what our issue is: waste in the system. Inefficiencies are driving cost, poor patient outcomes and frustration with all key actors: providers, pharma, payers, policymakers & patients. Today, I am excited to talk with Dr Nicolas Leupin (CMO at Molecular Partners) about his notion of value & the key to overcome waste. "People need to talk to each other!" he tells me when he explains that we collectively need to ask the right questions to the right people. Often they sit outside of our own expertise though. Drug developers talking to doctors, to software & data engineers ('don't forget the IT guy!'), data privacy lawyers, patients & payers at the same time! When did you do that for the last time? It's about courage & creativity to take action. But foremost, it's about trust, Nicolas reminds us. Put the patient at the center of your interest. Don't forget to ask them early when you design a trial - you may miss your goal and spend a lot of money. "Patient poor. Data rich" is his mantra to maximize as little as needed patients in a clinical trial while utilizing as much of pre-existing data as possible. For this to happen, what we need are effective software intraoperability and trustworthy partnerships. Like this episode? Don't forget to like wherever you saw our series.